Celebrating innovation in childhood cancer research – Children’s Cancer Institute
Children’s Cancer Institute shared the following post on LinkedIn:
“Children’s Cancer Institute is proud to share that two of our researchers, Professor Paul Ekert and Chelsea Mayoh, were featured in The Australian newspaper’s ‘Top 100 Innovators 2024’ list, published on 18 October.
The List recognises a selection of the nation’s best inventors and entrepreneurs and identifies some of the most exciting ideas emerging across the country.
This year, a special focus was placed on health and medical research in Australia, which was described as ‘proving fertile ground for a new generation of scientists and clinicians’.
Paul, Co-Head of the Institute’s Personalised Medicine Theme, and Chelsea, leader of our Bioinformatics team, made news last year when they published world-first research showing that many more children with cancer than previously realised could potentially benefit from immunotherapy, a type of therapy that uses the patient’s own immune system to fight cancer which has been used to great effect in the treatment of certain adult cancers.
Their findings could have significant implications for the treatment of children with solid tumours such as brain cancer, sarcoma and neuroblastoma, if successfully applied to the clinical setting.
The List’s editor, Helen Trinca, was reported as saying that while the Top 100 Innovators “doesn’t pretend to be a definitive list”, it does spotlight “talented people who, one way and another, are changing the way we live.”
Congratulations to Paul and Chelsea for this incredible recognition of your contributions to childhood cancer research. ”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023